Oncology roundtable report: how tech is transforming the landscape
Expert panellists address the key trends and challenges shaping the future of oncology, as they explore:
Report Clinical Studies Pharmaceutical Research and Development
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times.
We offer a full range of consulting, development and commercialisation services from a global network of offices in 37 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.
Navigating challenges in ADC development
Antibody-Drug Conjugates (ADCs) are notoriously tricky to develop, due to their delicate nature and the barriers facing their delivery. Andreas Dreps, Senior Vice President, Drug Development Services at ICON Biotech, highlights key obstacles in the development of ADCs and why the future remains bright for this targeted therapy, as he explores:
Article Clinical Studies Pharmaceutical Research and Development
Varying challenges in each stage of early phase development
In early stage drug development, biotechs face a multitude of challenges, from protocol development to generate the right scientific data required for further investment, to compliance and regulatory requirements, and the identification of strategic partnerships. In this report, discover insights from leading biotechs on:
Report Clinical Studies Pharmaceutical Research and Development
Increasing rare disease awareness brings promise to orphan drug innovation
rphan drug innovation has gone from strength to strength, propelled by advances in genetic medicine, such as mRNA therapies. However, challenges remain in patient identification and carrying out small-scale complex clinical trials. In this article, Will Maier, VP and Head of Centre for Rare Disease, ICON Biotech, explores the challenges and the necessary solutions to advance rare disease drug development in today’s dynamic landscape.
Article Clinical Studies Pharmaceutical Research and Development
Addressing obesity's impact across the disease spectrum
Obesity is a growing health concern worldwide, with at least 2.8 million people dying each year as a result of the disease. Additionally, the number of individuals living with obesity continues to increase annually across age, gender and geographic location. A complex condition, obesity has implications in inflammatory, metabolic and cardiovascular health — which, together, mean that advancing the treatment of obesity also means accounting for its relationships with other physiological systems and health conditions. Read the whitepaper to learn:
Whitepaper Clinical Studies Pharmaceutical Research and Development
Trends in Biotech Innovation
In the last few decades, biotechnology innovations have advanced at a rapid rate. From gene editing to synthetic biology, biotech innovation has paved the way for new and innovative products and services that are changing the world. Gain access to a diverse range of articles from key opinion leaders on the most significant topics in biotech innovation. Download our eBook and explore topics such as:
Ebook Clinical Studies Pharmaceutical Research and Development
